Zorgstandaard Neurofibromatose type-2

91 / 106

91
[37]N. B. Thuijs, B. M. J. Uitdehaag, W. J. R. Ouwerkerk, P. Valk, W. P. Vandertop, and S. M. Peerdeman,
“Pediatric meningiomas in The Netherlands 1974–2010: a descriptive epidemiological case study,” Childs
Nerv. Syst., vol. 28, no. 7, pp. 1009–1015, Apr. 2012.
[38] R. S. Kotecha, E. M. Pascoe, E. J. Rushing, L. B. Rorke-Adams, T. Zwerdling, X. Gao, X. Li, S. Greene, A.
Amirjamshidi, S.-K. Kim, M. A. Lima, P.-C. Hung, F. Lakhdar, N. Mehta, Y. Liu, B. I. Devi, B. J. Sudhir, M.
Lund-Johansen, F. Gjerris, C. H. Cole, and N. G. Gottardo, “Meningiomas in children and adolescents: a
meta-analysis of individual patient data,” Lancet Oncol., vol. 12, no. 13, pp. 1229–1239, Dec. 2011.
[39] P. Bäumer, V. F. Mautner, T. Bäumer, M. U. Schuhmann, M. Tatagiba, S. Heiland, T. Kaestel, M.
Bendszus, and M. Pham, “Accumulation of non-compressive fascicular lesions underlies NF2
polyneuropathy,” J. Neurol., vol. 260, no. 1, pp. 38–46, Jul. 2012.
[40] R. M. Rine and S. Wiener-Vacher, “Evaluation and treatment of vestibular dysfunction in children,”
NeuroRehabilitation, vol. 32, no. 3, pp. 507–518, 2013.
[41]M. E. Baser, V.-F. Mautner, D. M. Parry, and D. G. R. Evans, “Methodological issues in longitudinal
studies: vestibular schwannoma growth rates in neurofibromatosis 2,” J. Med. Genet., vol. 42, no. 12, pp.
903–906, Dec. 2005.
[42] International RadioSurgery Association, “Stereotactic Radiosurgery for Patients with Vestibular
Schwannomas,” Radiosurgery Practice Guideline Report, Mei 2006.
[43]Nederlandse Vereniging voor Neurochirurgie, “Patienteninformatie over brughoektumor.” Apr-2009.
[44] S. Goutagny and M. Kalamarides, “Meningiomas and neurofibromatosis,” J. Neurooncol. , vol. 99, no. 3,
pp. 341–347, Aug. 2010.
[45] L. M. DeAngelis, “Brain tumors,” N. Engl. J. Med., vol. 344, no. 2, pp. 114–123, Jan. 2001.
[46]O. N. Gottfried, W. Gluf, A. Quinones-Hinojosa, P. Kan, and M. H. Schmidt, “Spinal meningiomas: surgical
management and outcome,” Neurosurg. Focus, vol. 14, no. 6, p. e2, Jun. 2003.
[47]N. J. Patronas, N. Courcoutsakis, C. M. Bromley, G. L. Katzman, M. MacCollin, and D. M. Parry,
“Intramedullary and spinal canal tumors in patients with neurofibromatosis 2: MR imaging findings and
correlation with genotype,” Radiology, vol. 218, no. 2, pp. 434–442, Feb. 2001.
[48] L. L. Mechtler and K. Nandigam, “Spinal cord tumors: new views and future directions,” Neurol. Clin. , vol.
31, no. 1, pp. 241–268, Feb. 2013.
[49] S. R. Plotkin, C. C. O’Donnell, W. T. Curry, C. M. Bove, M. MacCollin, and F. P. Nunes, “Spinal
ependymomas in neurofibromatosis Type 2: a retrospective analysis of 55 patients,” J. Neurosurg. Spine ,
vol. 14, no. 4, pp. 543–547, Apr. 2011.
[50]M. A. Pearson-Webb, M. I. Kaiser-Kupfer, and R. Eldridge, “Eye findings in bilateral acoustic (central)
neurofibromatosis: association with presenile lens opacities and cataracts but absence of Lisch nodules,”
N. Engl. J. Med., vol. 315, no. 24, pp. 1553–1554, Dec. 1986.
[51]Website van samenwerkende oogcentra van de Samenwerkende Topklinische Ziekenhuizen,
” geraadpleegd oktober-
2013. [Online]. Available:
[52] S. M. Meyers, F. A. Gutman, L. D. Kaye, and A. D. Rothner, “Retinal changes associated with
neurofibromatosis 2,” Trans. Am. Ophthalmol. Soc., vol. 93, pp. 245–252; discussion 252–257, 1995.
[53]Oogcentra van Samenwerkende Topklinische Ziekenhuizen, “Macula pucker,” Macula pucker. [Online].
Available:
[Accessed: 02-Dec-2013].
[54] S. Mennel, C. H. Meyer, S. Peter, J. C. Schmidt, and P. Kroll, “Current treatment modalities for exudative
retinal hamartomas secondary to tuberous sclerosis: review of the literature,” Acta Ophthalmol. Scand.,
vol. 85, no. 2, pp. 127–132, Mar. 2007.
[55]D. A. Thomas, J. D. Trobe, and W. T. Cornblath, “Visual loss secondary to increased intracranial pressure
in neurofibromatosis type 2,” Arch. Ophthalmol., vol. 117, no. 12, pp. 1650–1653, Dec. 1999.
[56] T. D. Duane, W. Tasman, and E. A. Jaeger, “Chapter 36,” in Duane’s foundations of clinical
ophthalmology., Philadelphia: Lippincott, Williams & Wilkins, 1998, p. 5.
[57]A. A. Sandberg and J. F. Stone, The Genetics and Molecular Biology of Neural Tumours. Springer, 2008.